IX BiopharmaW260718 News

General Announcement-Formation of the Audit and Risk Committee and Reconstitution of the Board Committees

Oct 17 19:06

General Announcement-Press Release - iX Biopharma Appoints Dr. Brian Kennedy as New Scientific Advisor

Oct 14 17:39

Change - Announcement of Cessation-Retirement of Independent Director

Oct 1 06:45

General Announcement-Press Release - Business and Drug Development Updates - Wafermine and iXB 401

Sep 16 17:37

General Announcement-Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells

Sep 2 07:12

General Announcement-Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients

Aug 12 18:50

REPL-General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 22 17:39

General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 19 18:16